Should prophylactic mupirocin be prescribed after Rejuran (polynucleotide) injection in a typical adult patient without specific risk factors?

No Prophylactic Mupirocin After Rejuran Treatment

Prophylactic mupirocin should not be prescribed routinely after Rejuran (polynucleotide) injection in typical adult patients without specific risk factors.

Rationale

Rejuran treatment involves intradermal/subcutaneous polynucleotide injections for aesthetic purposes, which does not fall into any established category requiring antimicrobial prophylaxis. The available evidence addresses mupirocin use in fundamentally different clinical contexts:

When Mupirocin IS Indicated

Based on IDSA guidelines 1, 2, 1, mupirocin has specific, evidence-based roles:

• Treatment of active infections: For minor skin infections like impetigo and secondarily infected lesions (eczema, ulcers, lacerations), mupirocin 2% topical ointment is effective 1

• Decolonization for recurrent infections: Only after a patient develops recurrent skin and soft tissue infections despite optimizing wound care and hygiene measures 1. The regimen is mupirocin twice daily for 5-10 days, often combined with chlorhexidine body washes 2, 1

• Surgical prophylaxis in high-risk settings: Perioperative intranasal mupirocin reduces surgical site infections in cardiac surgery, orthopedic procedures with prosthetic implants, and other nongeneral surgeries 3, 4, 5. This requires MRSA colonization screening or high-risk patient profiles (COBRAS criteria: Cigarettes, Obesity, Bilateral IMA use, Breast size, Radiation, Renal failure, Age, Anorexia, A1C elevation, Steroids, Sex, Immunosuppression) 3

Why Rejuran Does NOT Require Prophylaxis

Aesthetic injections are fundamentally different from surgical procedures:

• No tissue disruption comparable to surgery requiring incision, implants, or extensive manipulation
• No evidence base supporting antimicrobial prophylaxis for cosmetic injectables
• The wound created is minimal—similar to routine vaccinations or blood draws, which never require prophylaxis
• Mupirocin prophylaxis studies focus on surgical site infections, not aesthetic procedures 4, 5

Risk-benefit analysis favors no prophylaxis:

• Unnecessary antibiotic exposure contributes to resistance development
• Mupirocin resistance can emerge with inappropriate use 6
• The baseline infection risk after aesthetic injections is extremely low with proper sterile technique
• No guideline recommends prophylaxis for cosmetic injectables [1-7]

Appropriate Infection Prevention for Rejuran

Instead of antibiotics, focus on evidence-based infection prevention:

Standard sterile technique:

• Proper skin antisepsis with alcohol-containing chlorhexidine or povidone-iodine
• Allow antiseptic to dry completely (minimum 3 minutes for chlorhexidine) 3
• Use sterile equipment and maintain aseptic technique

Patient hygiene instructions:

• Keep injection sites clean and dry
• Avoid touching or manipulating treated areas
• Maintain good hand hygiene 2, 1

When to Consider Mupirocin After Rejuran

Only prescribe mupirocin if specific high-risk factors are present:

Active MRSA colonization:

• Known nasal MRSA carrier status
• Recent MRSA infection history
• Consider nasal decolonization protocol: mupirocin twice daily for 5-10 days 2, 1

Severe immunocompromise:

• Active chemotherapy with neutropenia
• Severe cell-mediated immunodeficiency
• High-dose systemic corticosteroids (>20mg prednisone equivalent daily)
• In these cases, discuss whether aesthetic procedures should be deferred entirely

Signs of developing infection post-procedure:

• Increasing erythema, warmth, purulent drainage
• This requires treatment, not prophylaxis—culture the site and treat based on results 1, 8

Common Pitfalls to Avoid

• Don't conflate aesthetic procedures with surgery: The evidence for surgical prophylaxis does not apply to minimally invasive cosmetic injections
• Don't prescribe "just to be safe": This promotes resistance without evidence of benefit
• Don't use mupirocin for routine wound care: It's an antibiotic, not a wound healing agent
• Don't ignore proper technique: Sterile injection technique is far more important than prophylactic antibiotics

The single study mentioning Rejuran 9 addresses treatment of steroid-induced lipoatrophy and makes no mention of infection prophylaxis, confirming this is not a recognized concern in polynucleotide therapy.